![[awatar]](/static/gen/avatars/reenak12635/m0.png?2 "reenak12635"){kind=avatar}
AI in Oncology Market to reach $ 9.1 Billion by 2040
Overview of the AI in Oncology Market
Roots Analysis has published a report on the global AI in Oncology market, This market research report delivers a detailed and up-to-date analysis of the industry, covering market size, share, growth trends, key drivers, restraints, opportunities, and competitive landscape. Designed for business leaders, investors, and analysts, the report provides actionable intelligence to support strategic planning, market entry decisions, and long-term investment strategies.
Key Findings of the Study:
In terms of geographical regions, North America currently holds the highest atrial fibrillation treatment devices market share ( nearly 50%) .
Market Size in 2026: $9.6 Billion
Estimated Market Size in 2035: $29.0 Billion
CAGR (2026-2035): 13.1%
North America: Largest market in 2026
Asia-Pacific: Fastest growing region
To know more about other segments within AI in Oncology market, read here www.rootsanalysis.com
AI in Oncology Adoption in the Asia Pacific Region
Request for free sample, www.rootsanalysis.com
Competitive Landscape
The AI in Oncology Market has multiple key players in the market, which are profiled in the report also-
Berg (A part of BPGbio)
CancerCenter.AI
Concert AI
GE Healthcare
IBM Watson Health
iCAD
JLK Inspection
Median Technologies
Path AI
Roche Diagnostics
There are more key players involved in AI in Oncology market mentioned in the report
Key Market Segments
AI in Oncology Market Segmentation Insights
The market research report presents an in-depth analysis of the various AI in oncology companies, across different segments, as defined in the table below:
AI in Oncology Market: Market Segmentations
AI has been immensely utilized for data collection, evaluation, and real-time interpretation in the pharmaceutical industry. In fact, the integration of AI-based software solutions enables clinicians to detect cancer at an early stage and develop personalized therapies to treat a wide range of oncological indications. Additionally, AI-powered technology in oncology significantly reduces the cost of cancer testing and treatment. Driven by the significance offered by AI technology, experts believe that the use of AI in oncology market has enormous potential to generate revenue in the future.
▪ Solid malignancies
▪ Breast cancer
▪ Lung cancer
▪ Prostate cancer
▪ Colorectal cancer
▪ Brain tumor
▪ Others
▪ Hospitals
▪ Pharmaceutical companies
▪ Research Institutes
▪ Others
▪ North America
▪ Europe
▪ Asia-Pacific
▪ Rest of the World
Industry Experts on AI in Oncology Market
Discussions with multiple stakeholders in this domain influenced the opinions and insights presented in this study. The market report includes detailed transcripts of interviews conducted with the following individuals:
AI in oncology domain will mark a turning point in 2025. Douglas Flora, ( President, Association of Cancer Care Centers ), states, “For me, in 2025, the role of AI in oncology is pattern recognition and addressing some of the rote, mechanical tasks that eat up our days, I’m looking forward to future years, where AI might help us with making better decisions as well.”
▪ Chief Executive Officer, Mid-sized Company in the US
▪ Chief Executive Officer, Mid-sized Company in the US
▪ Chief Executive Officer, Small Company in Poland
▪ Chief Executive Officer, Mid-sized Company in Denmark
▪ Vice President, Mid-sized Company in the US
Key Questions Answered in the Report-
How is the Competitive Landscape of AI in Oncology Platform Providers Fragmented?
What is the Opportunity for AI in Oncology?
Which Region Holds the Largest Share of the AI in Oncology Market?
What are the Key Drivers of AI in Oncology Market?
What is artificial intelligence in oncology?
How big is AI in oncology industry?
What is the CAGR of AI in oncology market?
Which key geographical segment is likely to capture majority of AI in oncology market share, by 2035?
Which are the top companies in AI in oncology market?
Which type of service is primarily offered by companies engaged in the AI in oncology industry?
How is AI being used in oncology?
To read more about key questions answered and market insights, you can refer to the full report by Roots Analysis, www.rootsanalysis.com
Biologics Safety Testing Market
Radiopharmaceuticals Market
Laboratory Information Management Systems Market
Cell and Gene Therapy Manufacturing Market
Flow Cytometry Market
